Aldeyra Therapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
04 Février 2025 - 1:00PM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a
biotechnology company devoted to discovering and developing
innovative therapies designed to treat immune-mediated and
metabolic diseases, today announced that Todd C. Brady, M.D.,
Ph.D., President and Chief Executive Officer, will participate in a
fireside chat at Oppenheimer’s 35th Annual Healthcare Life Sciences
Conference. The conference is being conducted virtually on February
11, 2025.
Dr. Brady’s conversation with Francois Brisebois, Managing
Director, Senior Biotech Research Analyst, is scheduled to begin at
9:20 a.m. ET Tuesday, February 11, 2025. To view the live webcast,
log in to the Investors & Media section of the Aldeyra website
at https://ir.aldeyra.com. Following the fireside chat, the webcast
will be archived for 90 days.
About Aldeyra
Aldeyra Therapeutics is a biotechnology company devoted to
discovering innovative therapies designed to treat immune-mediated
and metabolic diseases. Our approach is to develop pharmaceuticals
that modulate protein systems, instead of directly inhibiting or
activating single protein targets, with the goal of optimizing
multiple pathways at once while minimizing toxicity. Our product
candidates include RASP (reactive aldehyde species) modulators
ADX-629, ADX-248, ADX-743, ADX-631, ADX-246, and chemically related
molecules for the potential treatment of systemic and retinal
immune-mediated and metabolic diseases. Our late-stage product
candidates are reproxalap, a RASP modulator for the potential
treatment of dry eye disease and allergic conjunctivitis, and
ADX-2191, a novel formulation of intravitreal methotrexate for the
potential treatment of retinitis pigmentosa.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250204881772/en/
Investor & Media Contact: Laura Nichols Tel: (781)
257-3060 investorrelations@aldeyra.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Aldeyra Therapeutics (NASDAQ:ALDX)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
